Asymmetric/Biological Unit(hide GO term definitions)
Chain A,C,E ( PCNA_HUMAN | P12004)
| molecular function |
|---|
| | GO:0003677 | | DNA binding | | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| | GO:0070182 | | DNA polymerase binding | | Interacting selectively and non-covalently with a DNA polymerase. |
| | GO:0030337 | | DNA polymerase processivity factor activity | | An enzyme regulator activity that increases the processivity of polymerization by DNA polymerase, by allowing the polymerase to move rapidly along DNA while remaining topologically bound to it. |
| | GO:0032405 | | MutLalpha complex binding | | Interacting selectively and non-covalently with the mismatch repair complex MutLalpha. |
| | GO:0003682 | | chromatin binding | | Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. |
| | GO:0003684 | | damaged DNA binding | | Interacting selectively and non-covalently with damaged DNA. |
| | GO:0032139 | | dinucleotide insertion or deletion binding | | Interacting selectively and non-covalently with double-stranded DNA containing a dinucleotide insertion or deletion. |
| | GO:0019899 | | enzyme binding | | Interacting selectively and non-covalently with any enzyme. |
| | GO:0030331 | | estrogen receptor binding | | Interacting selectively and non-covalently with an estrogen receptor. |
| | GO:0035035 | | histone acetyltransferase binding | | Interacting selectively and non-covalently with the enzyme histone acetyltransferase. |
| | GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0000701 | | purine-specific mismatch base pair DNA N-glycosylase activity | | Catalysis of the removal of purines present in mismatches, especially opposite oxidized purines, by cleaving the N-C1' glycosidic bond between the target damaged DNA base and the deoxyribose sugar. The reaction releases a free base and leaves an apurinic (AP) site. |
| | GO:0030971 | | receptor tyrosine kinase binding | | Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity. |
| biological process |
|---|
| | GO:0042769 | | DNA damage response, detection of DNA damage | | The series of events required to receive a stimulus indicating DNA damage has occurred and convert it to a molecular signal. |
| | GO:0006977 | | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | | A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage and resulting in the stopping or reduction in rate of the cell cycle. |
| | GO:0006281 | | DNA repair | | The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway. |
| | GO:0006260 | | DNA replication | | The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by initiation proteins, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA. |
| | GO:0006271 | | DNA strand elongation involved in DNA replication | | The process in which a DNA strand is synthesized from template DNA during replication by the action of polymerases, which add nucleotides to the 3' end of the nascent DNA strand. |
| | GO:0000082 | | G1/S transition of mitotic cell cycle | | The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated. |
| | GO:0008283 | | cell proliferation | | The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
| | GO:0006974 | | cellular response to DNA damage stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. |
| | GO:0034644 | | cellular response to UV | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers. |
| | GO:0030855 | | epithelial cell differentiation | | The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium. |
| | GO:0070987 | | error-free translesion synthesis | | The conversion of DNA-damage induced single-stranded gaps into large molecular weight DNA after replication by using a specialized DNA polymerase or replication complex to insert a defined nucleotide across the lesion. This process does not remove the replication-blocking lesions but does not causes an increase in the endogenous mutation level. For S. cerevisiae, RAD30 encodes DNA polymerase eta, which incorporates two adenines. When incorporated across a thymine-thymine dimer, it does not increase the endogenous mutation level. |
| | GO:0042276 | | error-prone translesion synthesis | | The conversion of DNA-damage induced single-stranded gaps into large molecular weight DNA after replication by using a specialized DNA polymerase or replication complex to insert a defined nucleotide across the lesion. This process does not remove the replication-blocking lesions and causes an increase in the endogenous mutation level. For example, in E. coli, a low fidelity DNA polymerase, pol V, copies lesions that block replication fork progress. This produces mutations specifically targeted to DNA template damage sites, but it can also produce mutations at undamaged sites. |
| | GO:0007507 | | heart development | | The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
| | GO:0006272 | | leading strand elongation | | The synthesis of DNA from a template strand in the 5' to 3' direction; leading strand elongation is continuous as it proceeds in the same direction as the replication fork. |
| | GO:0006298 | | mismatch repair | | A system for the correction of errors in which an incorrect base, which cannot form hydrogen bonds with the corresponding base in the parent strand, is incorporated into the daughter strand. The mismatch repair system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. |
| | GO:1902990 | | mitotic telomere maintenance via semi-conservative replication | | Any telomere maintenance via semi-conservative replication that is involved in mitotic cell cycle. |
| | GO:0006297 | | nucleotide-excision repair, DNA gap filling | | Repair of the gap in the DNA helix by DNA polymerase and DNA ligase after the portion of the strand containing the lesion has been removed by pyrimidine-dimer repair enzymes. |
| | GO:0033683 | | nucleotide-excision repair, DNA incision | | A process that results in the endonucleolytic cleavage of the damaged strand of DNA. The incision occurs at the junction of single-stranded DNA and double-stranded DNA that is formed when the DNA duplex is unwound. |
| | GO:0006296 | | nucleotide-excision repair, DNA incision, 5'-to lesion | | The endonucleolytic cleavage of the damaged strand of DNA 5' to the site of damage. The incision occurs at the junction of single-stranded DNA and double-stranded DNA that is formed when the DNA duplex is unwound. The incision follows the incision formed 3' to the site of damage. |
| | GO:0045739 | | positive regulation of DNA repair | | Any process that activates or increases the frequency, rate or extent of DNA repair. |
| | GO:0045740 | | positive regulation of DNA replication | | Any process that activates or increases the frequency, rate or extent of DNA replication. |
| | GO:0032077 | | positive regulation of deoxyribonuclease activity | | Any process that activates or increases the frequency, rate or extent of deoxyribonuclease activity, the hydrolysis of ester linkages within deoxyribonucleic acid. |
| | GO:0016925 | | protein sumoylation | | The process in which a SUMO protein (small ubiquitin-related modifier) is conjugated to a target protein via an isopeptide bond between the carboxyl terminus of SUMO with an epsilon-amino group of a lysine residue of the target protein. |
| | GO:0006275 | | regulation of DNA replication | | Any process that modulates the frequency, rate or extent of DNA replication. |
| | GO:0000083 | | regulation of transcription involved in G1/S transition of mitotic cell cycle | | Any process that regulates transcription such that the target genes are involved in the transition between G1 and S phase of the mitotic cell cycle. |
| | GO:0031297 | | replication fork processing | | The process in which a DNA replication fork that has stalled is restored to a functional state and replication is restarted. The stalling may be due to DNA damage, DNA secondary structure, bound proteins, dNTP shortage, or other causes. |
| | GO:0046686 | | response to cadmium ion | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. |
| | GO:0033993 | | response to lipid | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus. |
| | GO:0000723 | | telomere maintenance | | Any process that contributes to the maintenance of proper telomeric length and structure by affecting and monitoring the activity of telomeric proteins, the length of telomeric DNA and the replication and repair of the DNA. These processes includes those that shorten, lengthen, replicate and repair the telomeric DNA sequences. |
| | GO:0000722 | | telomere maintenance via recombination | | Any recombinational process that contributes to the maintenance of proper telomeric length. |
| | GO:0006283 | | transcription-coupled nucleotide-excision repair | | The nucleotide-excision repair process that carries out preferential repair of DNA lesions on the actively transcribed strand of the DNA duplex. In addition, the transcription-coupled nucleotide-excision repair pathway is required for the recognition and repair of a small subset of lesions that are not recognized by the global genome nucleotide excision repair pathway. |
| | GO:0019985 | | translesion synthesis | | The replication of damaged DNA by synthesis across a lesion in the template strand; a specialized DNA polymerase or replication complex inserts a defined nucleotide across from the lesion which allows DNA synthesis to continue beyond the lesion. This process can be mutagenic depending on the damaged nucleotide and the inserted nucleotide. |
| cellular component |
|---|
| | GO:0005663 | | DNA replication factor C complex | | A complex that loads the DNA polymerase processivity factor proliferating cell nuclear antigen (PCNA) onto DNA, thereby permitting processive DNA synthesis catalyzed by DNA polymerase. In eukaryotes the complex consists of five polypeptides. |
| | GO:0043626 | | PCNA complex | | A protein complex composed of three identical PCNA monomers, each comprising two similar domains, which are joined in a head-to-tail arrangement to form a homotrimer. Forms a ring-like structure in solution, with a central hole sufficiently large to accommodate the double helix of DNA. Originally characterized as a DNA sliding clamp for replicative DNA polymerases and as an essential component of the replisome, and has also been shown to be involved in other processes including Okazaki fragment processing, DNA repair, translesion DNA synthesis, DNA methylation, chromatin remodeling and cell cycle regulation. |
| | GO:0070557 | | PCNA-p21 complex | | A protein complex that contains the cyclin-dependent protein kinase inhibitor p21WAF1/CIP1 bound to PCNA; formation of the complex inhibits DNA replication. |
| | GO:0005813 | | centrosome | | A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0000784 | | nuclear chromosome, telomeric region | | The terminal region of a linear nuclear chromosome that includes the telomeric DNA repeats and associated proteins. |
| | GO:0043596 | | nuclear replication fork | | The Y-shaped region of a nuclear replicating DNA molecule, resulting from the separation of the DNA strands and in which the synthesis of new strands takes place. Also includes associated protein complexes. |
| | GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0030894 | | replisome | | A multi-component enzymatic machine at the replication fork which mediates DNA replication. Includes DNA primase, one or more DNA polymerases, DNA helicases, and other proteins. |
Chain B,D,F ( CDN1A_HUMAN | P38936)
| molecular function |
|---|
| | GO:0030332 | | cyclin binding | | Interacting selectively and non-covalently with cyclins, proteins whose levels in a cell varies markedly during the cell cycle, rising steadily until mitosis, then falling abruptly to zero. As cyclins reach a threshold level, they are thought to drive cells into G2 phase and thus to mitosis. |
| | GO:0019912 | | cyclin-dependent protein kinase activating kinase activity | | Catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein; increases the activity of a cyclin-dependent protein kinase (CDK). |
| | GO:0004861 | | cyclin-dependent protein serine/threonine kinase inhibitor activity | | Stops, prevents or reduces the activity of a cyclin-dependent protein serine/threonine kinase. |
| | GO:0046872 | | metal ion binding | | Interacting selectively and non-covalently with any metal ion. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0032403 | | protein complex binding | | Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0004860 | | protein kinase inhibitor activity | | Stops, prevents or reduces the activity of a protein kinase, an enzyme which phosphorylates a protein. |
| | GO:0031625 | | ubiquitin protein ligase binding | | Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
| biological process |
|---|
| | GO:0006977 | | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | | A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage and resulting in the stopping or reduction in rate of the cell cycle. |
| | GO:0000082 | | G1/S transition of mitotic cell cycle | | The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated. |
| | GO:0000086 | | G2/M transition of mitotic cell cycle | | The mitotic cell cycle transition by which a cell in G2 commits to M phase. The process begins when the kinase activity of M cyclin/CDK complex reaches a threshold high enough for the cell cycle to proceed. This is accomplished by activating a positive feedback loop that results in the accumulation of unphosphorylated and active M cyclin/CDK complex. |
| | GO:0007265 | | Ras protein signal transduction | | A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state. |
| | GO:0031100 | | animal organ regeneration | | The regrowth of a lost or destroyed animal organ. |
| | GO:0007049 | | cell cycle | | The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division. |
| | GO:0007050 | | cell cycle arrest | | A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M). |
| | GO:0006974 | | cellular response to DNA damage stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. |
| | GO:0071493 | | cellular response to UV-B | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-B radiation stimulus. UV-B radiation (UV-B light) spans the wavelengths 280 to 315 nm. |
| | GO:0034198 | | cellular response to amino acid starvation | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of amino acids. |
| | GO:0031668 | | cellular response to extracellular stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an extracellular stimulus. |
| | GO:0034605 | | cellular response to heat | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
| | GO:0071479 | | cellular response to ionizing radiation | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ionizing radiation stimulus. Ionizing radiation is radiation with sufficient energy to remove electrons from atoms and may arise from spontaneous decay of unstable isotopes, resulting in alpha and beta particles and gamma rays. Ionizing radiation also includes X-rays. |
| | GO:0090398 | | cellular senescence | | A cell aging process stimulated in response to cellular stress, whereby normal cells lose the ability to divide through irreversible cell cycle arrest. |
| | GO:0060574 | | intestinal epithelial cell maturation | | The developmental process, independent of morphogenetic (shape) change, that is required for a columna/cuboidal epithelial cell of the intestine to attain its fully functional state. A columnar/cuboidal epithelial cell of the intestine mature as they migrate from the intestinal crypt to the villus. |
| | GO:0097193 | | intrinsic apoptotic signaling pathway | | A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway starts with reception of an intracellular signal (e.g. DNA damage, endoplasmic reticulum stress, oxidative stress etc.), and ends when the execution phase of apoptosis is triggered. The intrinsic apoptotic signaling pathway is crucially regulated by permeabilization of the mitochondrial outer membrane (MOMP). |
| | GO:0042771 | | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | | A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage, and ends when the execution phase of apoptosis is triggered. |
| | GO:0071850 | | mitotic cell cycle arrest | | The process in which the mitotic cell cycle is halted during one of the normal phases (G1, S, G2, M). |
| | GO:2000134 | | negative regulation of G1/S transition of mitotic cell cycle | | Any cell cycle regulatory process that prevents the commitment of a cell from G1 to S phase of the mitotic cell cycle. |
| | GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| | GO:0030308 | | negative regulation of cell growth | | Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth. |
| | GO:0008285 | | negative regulation of cell proliferation | | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| | GO:0045736 | | negative regulation of cyclin-dependent protein serine/threonine kinase activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity. |
| | GO:0010629 | | negative regulation of gene expression | | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| | GO:0042326 | | negative regulation of phosphorylation | | Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule. |
| | GO:0030890 | | positive regulation of B cell proliferation | | Any process that activates or increases the rate or extent of B cell proliferation. |
| | GO:0010942 | | positive regulation of cell death | | Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. |
| | GO:1904031 | | positive regulation of cyclin-dependent protein kinase activity | | Any process that activates or increases the frequency, rate or extent of cyclin-dependent protein kinase activity. |
| | GO:0048146 | | positive regulation of fibroblast proliferation | | Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
| | GO:0043068 | | positive regulation of programmed cell death | | Any process that activates or increases the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes. |
| | GO:2000379 | | positive regulation of reactive oxygen species metabolic process | | Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process. |
| | GO:0050821 | | protein stabilization | | Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation. |
| | GO:2000278 | | regulation of DNA biosynthetic process | | Any process that modulates the frequency, rate or extent of DNA biosynthetic process. |
| | GO:0051726 | | regulation of cell cycle | | Any process that modulates the rate or extent of progression through the cell cycle. |
| | GO:0000079 | | regulation of cyclin-dependent protein serine/threonine kinase activity | | Any process that modulates the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity. |
| | GO:0007346 | | regulation of mitotic cell cycle | | Any process that modulates the rate or extent of progress through the mitotic cell cycle. |
| | GO:0033158 | | regulation of protein import into nucleus, translocation | | Any process that modulates the vectorial transfer of a protein from the cytoplasm into the nucleus, across the nuclear membrane. |
| | GO:0090399 | | replicative senescence | | A cell aging process associated with the dismantling of a cell as a response to telomere shortening and/or cellular aging. |
| | GO:0009411 | | response to UV | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers. |
| | GO:0010165 | | response to X-ray | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of X-ray radiation. An X-ray is a form of electromagnetic radiation with a wavelength in the range of 10 nanometers to 100 picometers (corresponding to frequencies in the range 30 PHz to 3 EHz). |
| | GO:0046685 | | response to arsenic-containing substance | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an arsenic stimulus from compounds containing arsenic, including arsenates, arsenites, and arsenides. |
| | GO:0051412 | | response to corticosterone | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosterone stimulus. Corticosterone is a 21 carbon steroid hormone of the corticosteroid type, produced in the cortex of the adrenal glands. In many species, corticosterone is the principal glucocorticoid, involved in regulation of fuel metabolism, immune reactions, and stress responses. |
| | GO:0042493 | | response to drug | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
| | GO:0051384 | | response to glucocorticoid | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects. |
| | GO:0055093 | | response to hyperoxia | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating increased oxygen tension. |
| | GO:0014070 | | response to organic cyclic compound | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| | GO:0010033 | | response to organic substance | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus. |
| | GO:0010243 | | response to organonitrogen compound | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organonitrogen stimulus. An organonitrogen compound is formally a compound containing at least one carbon-nitrogen bond. |
| | GO:0009636 | | response to toxic substance | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus. |
| | GO:0072331 | | signal transduction by p53 class mediator | | An intracellular signaling process that is induced by the cell cycle regulator phosphoprotein p53 or an equivalent protein. |
| | GO:0090400 | | stress-induced premature senescence | | A cellular senescence process associated with the dismantling of a cell as a response to environmental factors such as hydrogen peroxide or X-rays. |
| cellular component |
|---|
| | GO:0070557 | | PCNA-p21 complex | | A protein complex that contains the cyclin-dependent protein kinase inhibitor p21WAF1/CIP1 bound to PCNA; formation of the complex inhibits DNA replication. |
| | GO:0000307 | | cyclin-dependent protein kinase holoenzyme complex | | Cyclin-dependent protein kinases (CDKs) are enzyme complexes that contain a kinase catalytic subunit associated with a regulatory cyclin partner. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0048471 | | perinuclear region of cytoplasm | | Cytoplasm situated near, or occurring around, the nucleus. |
|
Description
